Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-03-14 @ 6:35 AM
Study NCT ID:
NCT01308294
Status:
TERMINATED
Last Update Posted:
2020-06-11
First Post:
2011-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |